Frequently Asked
Questions
What is VAi?
VAi is a subsidiary of Microhaem Scientifics focused on strengthening Uganda’s health system through vaccine access and local biopharmaceutical manufacturing.
Why was VAi created?
To reduce reliance on external supply chains and build sustainable, local capacity for health technologies following lessons from COVID-19.
What does VAi do today?
VAi is developing a GMP-compliant manufacturing facility.
Where is VAi located?
Plot 16 A-C, Martyrs Way
Ntinda, Kampala, Uganda
Ntinda, Kampala, Uganda
Is VAi regulated?
Yes. VAi works closely with Uganda’s National Drug Authority and relevant ethical and regulatory bodies.
Does VAi support research and innovation?
Yes. VAi invests in locally driven research and development to address regional health priorities.
What makes VAi different?
A long-term, systems-focused approach combining manufacturing, workforce development, and regulatory alignment.
How will VAi benefit Uganda?
By improving access to essential medicines, creating skilled jobs, reducing import dependence, and strengthening health system resilience.
Will VAi expand beyond Uganda?
Yes. Regional expansion is planned as production capacity and capabilities mature.
What products will VAi manufacture?
Vaccines, stem cell–based therapies, and peptide therapeutics, developed to international quality standards.
How does VAi ensure quality and safety?
Through GMP compliance, robust quality management systems, and strict adherence to regulatory requirements.
How can organizations partner with VAi?
Through research collaborations, technology transfer, training, and manufacturing partnerships.
Who does VAi collaborate with?
VAi works with government institutions, private sector partners, research organizations, and global health stakeholders.
What partnership opportunities are available?
- Research & development
- Capacity building and training
- Technology transfer
- Manufacturing and supply partnerships
Partners
